Resmed Inc logo

RMD - Resmed Inc Share Price

$195.89 2.8  1.4%

Last Trade - 2:53pm

Large Cap
Market Cap ÂŁ20.24bn
Enterprise Value ÂŁ20.60bn
Revenue ÂŁ2.23bn
Position in Universe 458th / 6854
Unlock RMD Revenue
Relative Strength (%)
1m -3.69%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,679 1,839 2,067 2,340 2,607 2,957 3,106 3,373 +12.0%
+1.9 +2.4 +2.3 +28.6 -2.0 +33.6 +20.4 +4.68
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 March 2021, ResMed Inc.revenues increased 6% to $2.32B. Net income decreased 37%to $279.4M. Revenues reflect Sleep and Respiratory Caresegment increase of 6% to $2.04B, Software as a Servicesegment increase of 6% to $277.8M. Net income was offset byResearch and development increase of 11% to $165.4M(expense), Amortization of acquired intangible asseincrease of 7% to $23.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for RMD
Graphical History


RMD Revenue Unlock RMD Revenue

Net Income

RMD Net Income Unlock RMD Revenue

Normalised EPS

RMD Normalised EPS Unlock RMD Revenue

PE Ratio Range

RMD PE Ratio Range Unlock RMD Revenue

Dividend Yield Range

RMD Dividend Yield Range Unlock RMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RMD EPS Forecasts Unlock RMD Revenue
Profile Summary

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Last Annual June 30th, 2020
Last Interim March 31st, 2021
Incorporated March 31, 1994
Public Since June 1, 1995
No. of Shareholders: 26
No. of Employees: 7,770
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 145,517,832
Free Float (0.0%)
Eligible for
RMD Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RMD
Upcoming Events for RMD
Wednesday 12th May, 2021
Dividend For RMD.AX - 0.0390 USD
Wednesday 12th May, 2021
Dividend For RMD.N - 0.3900 USD
Wednesday 12th May, 2021
Dividend For R1MD34.SA - 0.5232 BRL
Tuesday 3rd August, 2021 Estimate
Q4 2021 Resmed Inc Earnings Release
Wednesday 27th October, 2021 Estimate
Q1 2022 Resmed Inc Earnings Release
Frequently Asked Questions for Resmed Inc
What is the Resmed Inc share price?

As of 2:53pm, shares in Resmed Inc are trading at $195.89, giving the company a market capitalisation of ÂŁ20.24bn. This share price information is delayed by 15 minutes.

How has the Resmed Inc share price performed this year?

Shares in Resmed Inc are currently trading at $195.89 and the price has moved by 20.74% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Resmed Inc price has moved by -16.53% over the past year.

What are the analyst and broker recommendations for Resmed Inc?

Of the analysts with advisory recommendations for Resmed Inc, there are there are currently 2 "buy" , 4 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Resmed Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Resmed Inc next release its financial results?

Resmed Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Resmed Inc dividend yield?

The Resmed Inc dividend yield is 0.81% based on the trailing twelve month period.

Does Resmed Inc pay a dividend?

Last year, Resmed Inc paid a total dividend of 1.56, and it currently has a trailing dividend yield of 0.81%. Looking ahead, shares in Resmed Inc are due to go ex-dividend on 2021-05-12 and the next dividend pay date is 2021-06-17.

When does Resmed Inc next pay dividends?

Resmed Inc are due to go ex-dividend on 2021-05-12 and the next dividend pay date is 2021-06-17. The historic dividend yield on Resmed Inc shares is currently 0.81%.

How do I buy Resmed Inc shares?

To buy shares in Resmed Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Resmed Inc?

Shares in Resmed Inc are currently trading at $195.89, giving the company a market capitalisation of ÂŁ20.24bn.

Where are Resmed Inc shares listed? Where are Resmed Inc shares listed?

Here are the trading details for Resmed Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: RMD
What kind of share is Resmed Inc?

Based on an overall assessment of its quality, value and momentum, Resmed Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Resmed Inc share price forecast 2021?

Shares in Resmed Inc are currently priced at $195.89. At that level they are trading at 9.48% discount to the analyst consensus target price of 0.00.

Analysts covering Resmed Inc currently have a consensus Earnings Per Share (EPS) forecast of 5.253 for the next financial year.

How can I tell whether the Resmed Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Resmed Inc. Over the past six months, the relative strength of its shares against the market has been -23.2%. At the current price of $195.89, shares in Resmed Inc are trading at -1.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Resmed Inc PE Ratio?

The Resmed Inc PE ratio based on its reported earnings over the past 12 months is 60.82. The shares are currently trading at $195.89.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Resmed Inc?

Resmed Inc's management team is headed by:

Peter Farrell - NEC
David Pendarvis - CAD
Ronald Taylor - LED
Brett Sandercock - CFO
Robert Douglas - PRE
Michael Farrell - CEO
Jim Hollingshead - CEX
Carol Burt - IND
Rajwant Sodhi - CEX
Karen Drexler - IND
Jan De Witte - IND
Justin Leong - CEX
Who are the major shareholders of Resmed Inc?

Here are the top five shareholders of Resmed Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.61% (15.4m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 6.08% (8.85m shares)
WCM Investment Management Investment Advisor
Percentage owned: 6.06% (8.82m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.35% (6.33m shares)
Capital World Investors Investment Advisor
Percentage owned: 3.67% (5.34m shares)
Similar to RMD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.